Relevant research suggested that drug-resistent NSCLC of hypoxia-driven is associated with expression of HIF-1α and VEGF; and in tumors driven primarily by the EGFR pathway, targeting HIF or key HIF-regulated genes may further enhance the effect of EGFR inhibition alone and delay drug resistance (45). Here, EGFR is linked to non-small cell lung carcinoma.